Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.03)
# 1,388
Out of 4,736 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $10.83 | +1.57% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $8.38 | +258.00% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $5.68 | +181.69% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $10.98 | +2,632.24% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $104.74 | -18.85% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $42.91 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $78.86 | +539.11% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $15.06 | +2,489.64% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $10.17 | -21.34% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $9.50 | +1,426.32% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $9.99 | +1,751.85% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $288.59 | -11.64% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $284.67 | +40.51% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $27.35 | +17.00% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $63.66 | +29.59% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $10.83
Upside: +1.57%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $8.38
Upside: +258.00%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $5.68
Upside: +181.69%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $10.98
Upside: +2,632.24%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $104.74
Upside: -18.85%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $42.91
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $78.86
Upside: +539.11%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $15.06
Upside: +2,489.64%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $10.17
Upside: -21.34%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $9.50
Upside: +1,426.32%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $9.99
Upside: +1,751.85%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $288.59
Upside: -11.64%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $284.67
Upside: +40.51%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $27.35
Upside: +17.00%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $63.66
Upside: +29.59%